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Background and purpose   Pediatric hip diseases account for 9% 
of all primary hip arthroplasties in the Norwegian Arthroplasty 
Register. We wanted to validate the diagnosis as reported to the 
register and to assess the quality of life of these patients after hip 
replacement.
Patients and methods   540 patients accepted to participate in 
this follow-up study (634 hips). All were less than 40 years of age 
and had been reported to the Norwegian Arthroplasty Register 
as having undergone a primary total hip arthroplasty (THA) 
between 1987 and 2007. The underlying diagnosis, age at diagno-
sis, and type of treatment given prior to the hip replacement were 
recorded from the original hospital notes. 
Results   The diagnoses reported to the Norwegian Arthroplasty 
Register were confirmed to be correct in 91% of all cases (538/592). 
For the 94 hips that had been treated due to Perthes’ disease or 
slipped capital femoral epiphysis (SCFE), the diagnosis was veri-
fied in 95% of cases (89/94). The corresponding proportion for 
inflammatory hip disease was 98% (137/140) and it was only 61% 
for primary osteoarthritis (19/31). The self reported quality of life 
(EQ-5D) was poorer for these young patients with THA than for 
persons in age-matched cohorts from Great Britain and Sweden, 
except for those with an underlying SCFE. 
Interpretation   The diagnoses reported to the Norwegian 
Arthroplasty Register as the underlying cause of THA were cor-
rect in 91% of cases. Individuals who undergo THA before the age 
of 40 have a reduced quality of life, except for those requiring a 
hip replacement because of SCFE.

Pediatric hip disorders such as developmental dysplasia of the 
hip (DDH), Perthes’ disease, and slipped capital femoral epiph-
ysis (SCFE) may lead to degenerative joint disease requiring a 
total hip arthroplasty (THA). According to data from the Nor-
wegian Arthroplasty Register (NAR), pediatric hip disorders 
account for 9% of all primary hip arthroplasties (Norwegian 
Arthroplasty Register Annual Report 2010). Studies on the 
long-term outcome of Perthes’ disease have indicated that the 
risk of later degenerative change varies according to age and 
the degree of involvement of the femoral head at presentation 
(Wiig et al. 2008). For SCFE, delayed diagnosis and treatment 
and the degree of residual deformity are associated with poorer 
functional outcome (Carney and Weinstein 1996, Gent and 
Clarke 2004). Only a few studies have addressed the quality of 
life of these 2 patient groups after hip replacement (Tellini et 
al. 2008, Wangen et al. 2008).
During the last 20–30 years, registries for THA have been 
established in all the Scandinavian countries. In Norway, an 
arthroplasty register has been running since 1987 (Havelin 
et al. 2000). Although reporting is not compulsory, the reg-
ister has data on 98% of all hip replacements (Espehaug et 
al. 2006). However, little has been published on the validity 
of such registry data (Pedersen et al. 2004, Arthursson et al. 
2005, Engesæter et al. 2011).
We therefore evaluated the accuracy of the diagnoses 
reported to the NAR for young adults. For patients with SCFE 
and Perthes’ disease, we also determined the age at diagnosis 
and types of treatment given prior to THA, and also the quality 
of life following hip replacement.
Patients and methods
Patients
In this study we included patients born after January 1, 1967 
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who had undergone THA and had been reported to the Nor-
wegian Arthroplasty Register (NAR) during the period 1987–
2007. 732 patients with 866 primary THAs were registered. 
19 patients were excluded due to death or emigration. The 
remaining 713 patients were approached by letter and invited 
to complete 2 questionnaires on hip diagnosis and quality of 
life. After one reminder 578 (81%) responded, and of these, 
540 patients (74% of the original cohort; corresponding to 634 
hips) gave permission for further information on their hip dis-
ease to be collected from their medical records in the relevant 
hospital(s) (Figure) (Engesaeter et al. 2011).
Questionnaires 
The first questionnaire was custom-made, and included ques-
tions on age at diagnosis and whether or not they agreed to the 
diagnosis that had been reported to the NAR. If they disagreed 
on the diagnosis, they were asked to give the correct diagnosis. 
The second questionnaire was EQ-5D, which is a stan-
dard health-related quality of life questionnaire that gives an 
EQ-5D index, where 0 is being dead and 100 is having the best 
possible health (Dolan 1997). An index of below 0 is ranked 
as a situation worse than death. We compared our findings 
with age-matched populations from Sweden and Great Britain 
(18–39 years) (Szende and Williams 2004).
Collection of data from the medical records
For patients who agreed to the diagnosis recorded in the NAR, 
and who had been registered with a diagnosis of rheuma-
toid arthritis, ankylosing spondylitis (morbus Bechterew) or 
sequelae of a femoral neck fracture, we accepted the diagnosis 
as being correct (155 hips) without collecting further informa-
tion from their medical records. For patients who had been reg-
istered as having primary osteoarthritis, hip dysplasia (DDH), 
Perthes’ disease/slipped capital femoral epiphysis (SCFE), or 
“others”—and for patients who disagreed about the diagnosis 
recorded—further information was obtained from the hospital 
notes (479 hips). The medical notes were searched for infor-
mation on age at the time of diagnosis and all the treatment 
given. Original radiographs were unavailable for many of the 
patients, due to Norwegian legislation which states that radio-
graphs do not need to be stored for more than 10 years after the 
last contact with the patient. The 634 hip replacements were 
performed in 48 hospitals. Data from the medical records were 
either collected directly from the 14 hospitals that performed 
5 or more THAs or were received by post from the remaining 
34 hospitals. Data on 22 hips (in 20 patients) were missing, 
and data on 20 hips (in 20 patients) were inconclusive, leav-
ing 500 patients (68% of the original cohort) with 592 THAs 
for further analysis (Figure 1). Patients reported to have the 
diagnoses sequelae of dysplasia or sequelae of dysplasia with 
luxation (dislocated at the time of THA) were pooled into one 
group (sequelae of DDH) for further analysis.
For diagnoses that were found to be incorrect after valida-
tion, we collected the original form submitted to the NAR and 
decided whether an incorrect diagnosis had been reported by 
the surgeon or whether there had been an error during the reg-
istration process.
Incidence of SCFE in Norway
The incidence of Perthes’ disease in Norway has been reported 
to be 9.2 per 105 (Wiig et al. 2008). There has been no simi-
lar study for SCFE, and an incidence was therefore calculated 
based on data from the Norwegian Patient Register (NPR). 
This is a mandatory, national registry to which all hospitals 
report regarding diagnoses and operation codes when patients 
are discharged. The incidence of SCFE for subjects less than 
16 years of age during the period 2000–2009 was calculated 
based on original data that had been reported concerning the 
annual number of hips diagnosed with SCFE (ICD-10 code 
M930), with a corresponding primary operation code. This 
was divided by the total number of individuals under 16 years 
of age in Norway during the same period. These data were 
received from Statistics Norway (www.ssb.no). To obtain the 
annual incidence of patients operated for SCFE, the mean 
annual number of operated hips was adjusted down based on 
the assumption that about 20–30% of patients with SCFE have 
bilateral operations (Hägglund et al. 1984, Loder 1996, Lehm-
ann et al. 2011). 
The Norwegian Arthroplasty Register
The registration form is filled in by the surgeon immediately 
after the operation and includes information on date of sur-
gery, underlying hip disorder classified into 1 of 9 categories 
(Table 1), the type of surgery, and whether it was primary sur-
gery or a re-operation (Havelin et al. 2000). The diagnoses of 
Perthes’ disease and SCFE are, however, pooled in the regis-
tration form as 1 common option. 
Ethics 
The study was approved by the Regional Ethics Committee for 
Medical and Health Research, reg. number 238.03, and writ-
ten informed consent was obtained from all the participants.
Flow of patients and THAs through the study.
540 patients with 634 THAs returned the 
questionnaire and permitted further data 
collection from medical notes 
500 patients with 592 THAs available for 
ﬁnal validation of diagnoses 
20 patients with 
missing data 
20 patients with 
inconclusive data Acta Orthopaedica 2012; 83 (2): 159–164  161
Statistics 
The data are summarized using mean (range). Means were 
compared using independent-samples t-test. The approach of 
Welch was used when equal variance was assumed, based on 
Levene’s test for equality. Chi-square tests were used to com-
pare attendees with non-attendees. Both hips were used when 
validating the correctness of reported diagnoses. There were 
no differences in the results when only 1 hip from each patient 
was used. Analyses of baseline characteristics, prior treatment, 
and quality of life were done on the patients. All analyses were 
performed with the SPSS software version 17.0.
Results
500 patients (344 females, 592 THAs) were included. Except 
for more females attending (p = 0.008), there were no sta-
tistically significant differences in baseline characteristics 
between the 500 attendees and the 213 non-attendees (Table 
1). Mean age at the time of hip replacement was 29 (12–41) 
years, with no significant differences between the sexes. Mean 
age at follow-up was 35 (17–41) years. 
538 of the 592 registry-based diagnoses were compared to 
questionnaires/medical records and judged to be correct in 
91% of cases (95% CI: 83–99) (Table 2). 
41% (240/592) of the THAs had been performed due to hip 
dysplasia (DDH) (142 hips), Perthes’ disease (72 hips), or 
SCFE (29 hips). For 3 patients, the diagnoses of both DDH 
and Perthes’ disease had been reported and had also been sug-
gested in the medical notes. For the purposes of this study, 
these patients were included in the Perthes’ disease group. 
Of the 240 THAs performed due to pediatric hip disorders, 
221 (92%) were correctly registered in the NAR (Table 2). 
Table 1. Baseline characteristics of attendees and non-attendees for the cohort and for subjects with THA second-
ary to Perthes’/SCFE reported to the NAR
  Attendees  95% CI  Non-attendees   95% CI  p-value 
Number of patients  500    232
Male, n (%)  218 (44%)  39–48  127 (55%)   48–61   0.008
Age at THA, mean    28.7  28–29    28.3   27–29   0.5
Type of underlying diagnosis, n (%)
  Primary osteoarthrosis    28 (5.6%)    3.5–7.7    19 (8.3%)     4.6–12   0.2
  JIA / RA    81 (16.1%)  13–20    25 (11%)     6.7–15   0.06
  Sequelae of femoral neck fracture    26 (5.2%)    3.2–7.2    19 (8.3%)     4.6–12   0.1
  Sequelae of DDH  129 (25.7%)  22–30    44(19%)   14–24   0.052
  Sequelae of Perthes’/ SCFE    91 (18.1%)  15–22    42 (18%)   13–23   1.0
  Ankylosing spondylitis    20 (4.0%)    2.2–5.8      8 (3.5%)     1.1–5.8   0.7 
  Acute femoral neck fracture      2 (0.4%)  –1.6 to 2.4      0     0.3
  Others  126 (25.1%)  21–29    73 (32%)   25–38   0.06
Perthes’ disease/SCFE    91      42
  Male, n (%)    61 (67%)  57–77    32 (76%)     9.3–18   0.3
  Age at THA, mean    27.5  26–29    25.8   24–28   0.2
JIA: juvenile idiopathic arthritis; RA: rheumatoid arthritis; DDH: developmental dysplasia of the hip; 
SCFE: slipped capital femoral epiphysis.
Table 2. Validation of diagnoses reported to the Norwegian Arthroplasty Register based on 
the original medical records and patient self-reporting
Diagnosis as reported to the NAR  No. of THAs  Correct diagnosis  95% CI
Primary osteoarthrosis  31    19 (61%)    44–79
JIA / RA  112  109 (97%)    94–100
Sequelae of femoral neck fracture  26    25 (96%)    87–104
Sequelae of DDH  150  132 (88%)    83–93
Sequelae of Perthes’/SCFE  94    89 (95%)    90–99
Ankylosing spondylitis (morbus Bechterew)  28    28 (100%)  100–100
Acute fracture of the femoral neck   2      2 (100%)  100–100
Others, specified  145  134 (92%)    84–101
Missing diagnosis  4      0        0–0
Total  592 538
Abbreviations: See Table 1.162  Acta Orthopaedica 2012; 83 (2): 159–164
18 hips that had been incorrectly reported as hip dysplasia 
were validated to be Perthes’ disease (5 hips), SCFE (1 hip), 
or other specified diagnoses (12 hips). 13 hips that had been 
incorrectly reported as primary osteoarthritis were re-diag-
nosed as hip dysplasia or other specified pathologies. 98% of 
hips (137/140) that were operated due to rheumatoid arthritis 
or ankylosing spondylithis had been correctly diagnosed ini-
tially (Table 2). 
43 of the 54 incorrect diagnoses registered in the NAR were 
due to mistakes made by the surgeons in filling in the forms. 
However, for 8 hips reported as “other specified diagnosis”, the 
surgeon had also noted the correct diagnosis but this had not 
been registered correctly in the NAR (4 sequelae of femoral 
neck fracture, 3 SCFE, and 1 juvenile idiopathic arthritis/RA). 
3 hips had been reported correctly on the form by the surgeon 
but had been wrongly registered by the secretary at the NAR.
101 of 500 subjects (20%) underwent THA due to Perthes’ 
disease (72 patients, 52 males) or SCFE (29 patients, 16 
females) (Table 3). None of these had had bilateral THA. For 
the 72 patients with Perthes’ disease, information on treatment 
prior to the THA was available for 44. 24 patients had under-
gone surgery, while 20 had only received nonoperative treat-
ment. For patients with SCFE, age at diagnosis and operation 
was 13 (10–15) years. 1 patient presented with symptoms at 
the age of 24 years and underwent THA 7 years later. 
Quality of life, EQ-5D
The mean EQ-5D index score for all subjects (500 patients) 
was 71 (8–100), 73 for males and 70 for females (p = 0.2), 
which was lower than that reported for an age-matched cohort 
in Sweden (89) and the UK (86) (p < 0.001). The mean score 
for those who underwent THA due to SCFE was significantly 
higher than that reported for those with Perthes’ (81 vs. 74; 
p = 0.04) or hip dysplasia (81 vs. 69; p = 0.008) (Table 4). The 
score for those operated because of SCFE was similar to that 
reported for an age-matched cohort in the UK (p = 0.13), but 
it was lower than that reported for an age-matched population 
in Sweden (p = 0.03).
Incidence of SCFE
The annual number of hips operated for SCFE that were 
reported to the NPR during the period 2000–2009 varied from 
29 to 46, with a mean of 38, giving an annual incidence of 
diagnosed hips with SCFE of 4 per 105 for children below the 
age of 16 years. When adjusting for bilaterality, this gave an 
annual incidence of patients with SCFE of about 3 per 105. 
Discussion
We found that the underlying cause of total hip replacement 
was correctly reported to the NAR in 91% of all subjects less 
than 40 years of age and in 95% of patients operated due to 
Perthes’ disease or SCFE. Except for those operated due to an 
underlying SCFE, quality of life as assessed by the EQ-5D 
index was poorer than in age-matched cohorts. 
The strengths of our study include the high number of par-
ticipants and the collection of additional data from the medical 
records. Except for gender, there were no statistically signif-
icant differences between the baseline data of the 213 non-
attendees and those of the attendees. This was not unexpected, 
since females are more liable to respond to surveys (Hill et 
al. 1997). Thus, there is little reason to believe that our cohort 
was flawed by selection bias.Our findings regarding validation 
of diagnoses compare favorably with a study from the Danish 
Hip Arthroplasty Register involving 459 patients (Pedersen 
et al. 2004). After having reviewed the medical records and 
preoperative radiographs, these authors found that a reported 
diagnosis had a positive predictive value of 84%. The outcome 
most probably reflects difficulties in assessing an underly-
ing diagnosis in older age groups, as secondary degenerative 
changes tend to obscure underlying pathologies. 
Table 3. Frequency of different hip disorders after validation. In 5 
hips, 2 diagnosis were likely: 2 hips showed RA and DDH (same 
patient) and 3 hips showed DDH and Perthes’ disease
Diagnosis  Correct numbers after validation
 (hips)
Primary arthrosis  18
JIA / RA  110
Sequelae of femoral neck fracture  31
Sequelae of DDH  142
Sequelae of Perthes’ disease  72
Sequelae of SCFE  29
Ankylosing spondylitis   30
Acute fracture of the femoral neck  2
Others, specified  162
Missing diagnosis  0
Abbreviations: See Table 1.
Table 4. EQ-5D index for patients with different diagnoses
Diagnosis  EQ-5D scores a   (95% CI)
 
Primary osteoarthrosis  73   61–85
JIA / RA   66  61–71
Sequelae of femoral neck fracture   68   59–77
Sequelae of DDH   69   65–73
Sequelae of Perthes   74   70–79
Sequelae of SCFE  81   75–87
Ankylosing spondylithis   73   64–82
Acute fracture of the femoral neck b   44   36–52
Others, specified   74   70–78
All diagnoses   71   69–73
 
a 0 = worse imaginable health; 100 = best possible health.
b Only 2 patients were operated due to acute fracture of the femoral 
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The observation that primary osteoarthritis was the diag-
nosis that was most commonly incorrectly reported was not 
unexpected, since severe arthritis warranting a THA at this 
young age would tend to obscure an underlying diagnosis 
such as DDH, Perthes’ disease, or SCFE (Murray 1965).
Children with Perthes’ disease had their diagnosis at 7 years 
of age; one third of them had undergone surgical treatment 
and slightly less than one third had had nonoperative treat-
ment alone. According to the medical notes, the remainder 
had received no treatment at all—although 17 of these patients 
reported otherwise in the questionnaire. This controversy may 
be due in part to inaccurate medical notes, recall bias, or both. 
For those with SCFE, age at diagnosis was slightly higher—
around 12 years—and all but 1 had had prompt surgery at the 
time of diagnosis. 
The initial treatment of Perthes’ disease depends on age 
and the severity of femoral head necrosis (Wiig et al. 2008). 
For SCFE, the standard treatment is operative stabilization of 
the femoral epiphysis (Loder et al. 2008), aiming at preven-
tion or delay of degenerative change (Carney et al. 1991). 
In the present study, all but 1 of the patients with SCFE and 
one third of those with Perthes’ disease had hip-preserving 
surgery as adolescents. Since most of the initial radiographs 
were unavailable, we could not determine whether those 
receiving surgery for Perthes’ disease were more severely 
affected than those who were treated nonoperatively. Like-
wise, we were unable to determine the degree of slip prior to 
initial surgery. 
Calculation of the annual incidence of SCFE in children less 
than 16 years was based on the NPR. Diagnoses of SCFE in 
the NPR are not validated, but a study from Arthurson et al. 
(2005) reported a difference of only 3.4% in data reported to 
this mandatory, national register compared to data reported to 
the NAR from a single hospital. All hospitals are obliged to 
report their patients to this administrative register, and there 
is little reason to believe that patients with SCFE were under- 
or over-represented. The NPR contains information on the 
number of operated hips only, not to the number of operated 
children. However, in a recent study, we showed that 30% of 
children with SCFE suffer bilateral involvement (Lehmann et 
al. 2011), providing a ratio on which to base the estimated 
incidence. This number is in accordance with that reported 
by other authors (Hägglund et al. 1984, Loder 1996). More-
over, none of the hospitals performed prophylactic fixation 
of the contralateral hip during the study period. The annual 
incidence of 3 per 105 also compares well with other studies 
(Loder et al. 2000, Krauspe et al 2004). In comparison, the 
incidence of Perthes’ disease was found to be 9 per 105  in a 
large, randomized national trial (Wiig et al. 2008). 
When comparing the number of operated prosthesis in 
SCFE or Perthes’disease with the incidences of the diseases 
(3 per 105  for SCFE and 9 per 105  for Perthes’ disease), we 
can see that the risk of undergoing THA was about the same 
for the 2 diseases. 
Of those patients who underwent THA as a result of SCFE, 
more than half of them (16 of 29) were females. This was 
rather surprising since SCFE is seen more frequently in males 
(2:1) (Loder et al. 2000, Gholve et al. 2009). One explanation 
may be that girls suffer a more severe slip than boys. Again, 
due to the unavailability of the initial radiographs, we could 
not investigate this in detail. One could speculate that there 
is a diagnostic delay leading to a more severe slip in girls, 
since doctors are more prone to consider SCFE as a possible 
diagnosis in males. A previous study of 67 patients with SCFE 
from our institution supports this, in that the female patients 
had almost 2 months longer duration of symptoms and nearly 
two-thirds had a moderate or severe slip compared to one third 
of the boys (Lehmann et al. 2011). Longer duration of symp-
toms is known to increase the severity of the slip (Loder et al. 
2006).
In this study, we found that the quality of life after THA 
is reduced for patients below 40 years of age as compared 
to healthy age-matched controls. This has also been demon-
strated by Wangen et al. (2008) in a study of 49 patients aged 
30 or less. They found a mean EQ-5D index of 68 as compared 
to 71 in our study. In comparison, indices from age-matched 
Swedish or British cohorts have been reported as being 85–90 
(Szende and Williams 2004). When subdivided into different 
diagnoses, we found that patients who had been operated due 
to SCFE had a better quality of life than the other groups. The 
reasons for this are unclear, but one explanation may be that 
the femoral head alone, and not the acetabulum, is involved 
in the underlying disease. In another study from the NAR 
(Engesæter et al. 2003), it was found that revision rates for 
patients requiring THA due to Perthes’ disease/SCFE were 
lower than for other diagnoses, but since both Perthes’ disease 
and SCFE are reported under the same tick box in the registra-
tion form, it was not possible to ascertain whether SCFEs or 
the Perthes’ disease caused the favorable results in that study. 
In the next revision of the NAR form, the diagnosis of Perthes’ 
disease and SCFE will be registered separately. 
In conclusion, data held in the NAR on the underling diag-
nosis for THA in young adults was of high quality, with 91% 
of the diagnoses being correctly reported. THA patients had 
a poorer quality of life than those in age-matched cohorts in 
Sweden and the UK, except for those who underwent THA as 
a result of SCFE.
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